NEAR-TOTAL REDUCTION IN VERAPAMIL BIOAVAILABILITY BY RIFAMPIN - ELECTROCARDIOGRAPHIC CORRELATES

被引：29

作者：

BARBARASH, RA

BAUMAN, JL

FISCHER, JH

KONDOS, GT

BATENHORST, RL

机构：

[1] UNIV ILLINOIS,DEPT PHARM PRACTICE,CLIN PHARMACOKINET LAB,CHICAGO,IL 60612

[2] UNIV ILLINOIS,DEPT MED,CARDIOL SECT,CHICAGO,IL 60612

[3] WASHINGTON UNIV,JEWISH HOSP ST LOUIS,DIV CARDIOL,ST LOUIS,MO 63110

来源：

CHEST | 1988年 / 94卷 / 05期

关键词：

D O I：

10.1378/chest.94.5.954

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：954 / 959

页数：6

共 29 条

[21]

RAHN KH, 1985, NEW ENGL J MED, V312, P920

[22] EFFECTS OF INTRAVENOUS AND CHRONIC ORAL VERAPAMIL ADMINISTRATION IN PATIENTS WITH SUPRAVENTRICULAR TACHYARRHYTHMIAS [J].

RINKENBERGER, RL ;

PRYSTOWSKY, EN ;

HEGER, JJ ;

TROUP, PJ ;

JACKMAN, WM ;

ZIPES, DP .

CIRCULATION, 1980, 62 (05) :996-1010

[23]

RUTLEDGE DR, 1987, CLIN PHARMACOL THER, V41, P245

[24] CALCIUM-ANTAGONISTS FOR PRINZMETALS VARIANT ANGINA, UNSTABLE ANGINA AND SILENT-MYOCARDIAL-ISCHEMIA - THERAPEUTIC TOOL AND PROBE FOR IDENTIFICATION OF PATHOPHYSIOLOGIC MECHANISMS [J].

STONE, PH .

AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (03) :B101-B115

[25] CALCIUM MODULATORS - FUTURE AGENTS, FUTURE USES [J].

TRACY, TS ;

BLACK, CD .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1987, 21 (7-8) :575-583

[26]

WILKINSON GR, 1975, CLIN PHARMACOL THER, V18, P377

[27] LONG-TERM THERAPY OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA - A RANDOMIZED, DOUBLE-BLIND COMPARISON OF DIGOXIN, PROPRANOLOL AND VERAPAMIL [J].

WINNIFORD, MD ;

FULTON, KL ;

HILLIS, LD .

AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (08) :1138-1139

[28] ROLE OF CALCIUM-ANTAGONISTS IN SYSTEMIC HYPERTENSION [J].

ZANCHETTI, A .

AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (03) :B130-B136

[29]

1986, AM STAT, V40, P52

← 1 2 3 →